Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial.
Cho BC, Lee JS, Wu YL, Cicin I, Dols MC, Ahn MJ, Cuppens K, Veillon R, Nadal E, Dias JM, Martin C, Reck M, Garon EB, Felip E, Paz-Ares L, Mornex F, Vokes EE, Adjei AA, Robinson C, Sato M, Vugmeyster Y, Machl A, Audhuy F, Chaudhary S, Barlesi F. Cho BC, et al. Among authors: cuppens k. J Thorac Oncol. 2023 Dec;18(12):1731-1742. doi: 10.1016/j.jtho.2023.08.018. Epub 2023 Aug 18. J Thorac Oncol. 2023. PMID: 37597750 Free article. Clinical Trial.
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN).
Bar J, Peled N, Schokrpur S, Wolner M, Rotem O, Girard N, Aboubakar Nana F, Derijcke S, Kian W, Patel S, Gantz-Sorotsky H, Zer A, Moskovitz M, Metro G, Rottenberg Y, Calles A, Hochmair M, Cuppens K, Decoster L, Reck M, Limon D, Rodriguez E, Astaras C, Bettini A, Häfliger S, Addeo A. Bar J, et al. Among authors: cuppens k. J Thorac Oncol. 2023 Feb;18(2):169-180. doi: 10.1016/j.jtho.2022.10.004. Epub 2022 Oct 25. J Thorac Oncol. 2023. PMID: 36307041 Free article.
The path forward in early-stage lung cancer.
Cuppens K, Baas P. Cuppens K, et al. Transl Lung Cancer Res. 2023 Jan 31;12(1):11-13. doi: 10.21037/tlcr-22-546. Epub 2022 Dec 30. Transl Lung Cancer Res. 2023. PMID: 36762062 Free PMC article. No abstract available.
A rare central thoracic tumor.
Cuppens K, Delcroix M, Van Raemdonck D, Meyns B, Sciot R, Debiec-Rychter M, Vansteenkiste JF. Cuppens K, et al. J Thorac Oncol. 2014 Jun;9(6):897-9. doi: 10.1097/JTO.0000000000000162. J Thorac Oncol. 2014. PMID: 24828668 Free article. No abstract available.
Sjögren's Syndrome Caused by PD-1 Inhibition in a Lung Cancer Patient.
Caeyman A, Vandekerckhove O, Pat K, Wynants J, Weytjens K, de Wergifosse I, Cuppens K. Caeyman A, et al. Among authors: cuppens k. Case Rep Oncol. 2023 Oct 11;16(1):1095-1099. doi: 10.1159/000532098. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37900791 Free PMC article.
Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study.
Cuppens K, Lodewyckx L, Demedts I, Decoster L, Colinet B, Deschepper K, Janssens A, Galdermans D, Pieters T; REVEAL Study Group. Cuppens K, et al. Drugs Real World Outcomes. 2021 Jun;8(2):141-152. doi: 10.1007/s40801-021-00243-w. Epub 2021 Mar 12. Drugs Real World Outcomes. 2021. PMID: 33710523 Free PMC article.
38 results